Alcon AG
NYSE:ALC
Relative Value
The Relative Value of one ALC stock under the Base Case scenario is 115.35 USD. Compared to the current market price of 78.47 USD, Alcon AG is Undervalued by 32%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
ALC Competitors Multiples
Alcon AG Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
CH |
Alcon AG
NYSE:ALC
|
35.6B USD | 4.1 | 40.1 | 17.9 | 36.3 | ||
JP |
Hoya Corp
TSE:7741
|
6.1T JPY | 8.1 | 36.4 | 22 | 27.1 | ||
DK |
Coloplast A/S
CSE:COLO B
|
202.6B DKK | 8.1 | 41.6 | 27.2 | 31.7 | ||
US |
Align Technology Inc
NASDAQ:ALGN
|
22.6B USD | 5.9 | 50.8 | 27.1 | 33 | ||
US |
Cooper Companies Inc
NYSE:COO
|
18B USD | 4.9 | 61.7 | 22.6 | 38.4 | ||
KR |
H
|
HLB Inc
KOSDAQ:028300
|
13T KRW | 302.7 | -68.7 | -111.9 | -103.3 | |
UK |
ConvaTec Group PLC
LSE:CTEC
|
5.8B GBP | 3.4 | 55.1 | 47 | 51.1 | ||
CN |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
50.8B CNY | 12.9 | 30.7 | 26.6 | 26.6 | ||
US |
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
6.3B USD | 1.6 | -47.8 | 12.2 | 26.2 | ||
CH |
Ypsomed Holding AG
SIX:YPSN
|
5.2B CHF | 10.2 | 71.3 | 33.7 | 65.8 | ||
CA |
B
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.1B USD | 1.2 | -19.6 | 15.6 | 43.6 |